Novavax
NVAX
7.47
-0.25
-3.24%
Novavax
US · NVAX
#2865 by market cap
Listed 1970
7.47
-0.25
-3.24%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Recent news
-
Company notice
Novavax | 8-K: Current reportSEC · 2026/10/30
-
B. Riley Adjusts Price Target on Novavax to $16 From $18, Keeps Buy RatingMT Newswires · 2026/11/6
-
Rating change
BofA Adjusts Price Target on Novavax to $8 From $7, Keeps Underperform RatingMT Newswires · 2026/10/9
-
Rating change
Citi Maintains Novavax(NVAX.US) With Sell Rating, Raises Target Price to $8Market Newswire · 2026/10/15
-
Company notice
Novavax | 10-Q: Quarterly reportSEC · 2026/11/5
-
B. Riley Securities Maintains Novavax(NVAX.US) With Buy Rating, Cuts Target Price to $16Market Newswire · 2026/11/7
-
Company notice
Novavax | SCHEDULE 13G: OthersSEC · 2026/10/17
-
Rating change
Citigroup Maintains Sell on Novavax, Raises Price Target to $8Benzinga · 2026/10/16
-
Rating change
Novavax Is Maintained at Sell by CitigroupDow Jones · 2026/10/16
-
Rating change
Cantor Fitzgerald Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $18Market Newswire · 2026/10/27
-
Novavax to Participate in Jefferies London Healthcare ConferencePR Newswire · 2026/11/12
-
Rating change
Bank of America Securities Remains a Sell on Novavax (NVAX)TipRanks · 2026/10/23
-
BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Cuts Target Price to $7Market Newswire · 2026/11/6
-
Rating change
BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Raises Target Price to $8Market Newswire · 2026/10/9
-
Rating change
Citi Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $8Market Newswire · 2026/10/16
-
These Analysts Just Made A Huge Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS ForecastsSimply Wall St · 2026/11/12
-
Company notice
Novavax | 8-K: Novavax Reports Third Quarter 2026 Financial Results and Operational HighlightsSEC · 2026/11/5
-
Rating change
Novavax Price Target Raised to $8.00/Share From $7.00 by CitigroupDow Jones · 2026/10/16
-
Rating change
BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $8Market Newswire · 2026/10/23
-
Company notice
Novavax | SCHEDULE 13G: OthersSEC · 2026/11/10
-
Rating change
Cantor Fitzgerald Sticks to Its Buy Rating for Novavax (NVAX)TipRanks · 2026/8/7
-
Novavax Halts Omicron Booster Study, Raising Fresh Questions for NVAX InvestorsTipRanks · 2026/10/24
-
Company notice
Novavax | SCHEDULE 13G: OthersSEC · 2026/8/7
-
Rating change
Analysts Offer Insights on Healthcare Companies: Helus Pharma (HELP), Ultragenyx Pharmaceutical (RARE) and Novavax (NVAX)TipRanks · 2026/9/21
-
Earnings Preview: Novavax to Report Financial Results Pre-market on November 05Market Newswire · 2026/10/31
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:01:36 · For reference only, not investment advice and not tailored to your situation.
Novavax discussion 0 comments